BSE filing, NSE: GUJTHEM. Summary written from the filing by ALFA Finder's alert engine.
Gujarat Themis Biosyn Ltd: key numbers
- Share price
- ₹371.80
- Market cap
- ₹4,839 Cr
- Revenue (annual)
- ₹165.8 Cr
- Net profit (annual)
- ₹46.68 Cr
- P/E (TTM)
- 99.4×Sector 46.1×
- Promoter holding
- 59.33%-11.53% QoQ
- FII holding
- 3.80%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Gujarat Themis Biosyn Ltd
All →Gujarat Themis Biosyn Board Meeting Date
Gujarat Themis Biosyn scheduled its board meeting for 4 Nov 2026 to approve Q2 and H2 un-audited results. No financial figures are disclosed in this advance intimation.
Gujarat Themis Biosyn Other Announcement
Gujarat Themis Biosyn clarified that its 9 October 2026 credit-rating intimation was uploaded in error and should be disregarded. No substantive business event is reported.
Gujarat Themis Biosyn Other Announcement
Gujarat Themis Biosyn Limited submitted the mandatory quarterly compliance certificate under SEBI Regulation 74(5) regarding dematerialization of shares for the quarter ended September 30, 2026.
Gujarat Themis Biosyn Annual General Meeting
Gujarat Themis Biosyn Ltd held its 45th Annual General Meeting on September 30, 2026, to deliberate on ordinary and special business resolutions.
Gujarat Themis Biosyn Annual General Meeting
Gujarat Themis Biosyn issued a corrigendum to its 45th AGM notice, updating the preferential issue resolution regarding share price, issue size, and allottee details.
Gujarat Themis Biosyn Acquisition Worth ₹1,300 Cr
Gujarat Themis Biosyn Limited acquired MicroBiopharm Japan Co. Ltd. for approximately ₹1,300 Crore. This acquisition expands its pharmaceutical CDMO capabilities.
- Value
- ₹1,300 Cr
Other board meeting date announcements
All →GTV Engineering Board Meeting Date
GTV Engineering scheduled a Board Meeting for 5 November 2026 to approve unaudited Q2 and half-year financial results. No new information is disclosed beyond the meeting notice.
Elixir Capital Board Meeting Date
Elixir Capital Ltd notified BSE that its Board will meet on 6 Nov 2026 to consider Q2/H1FY27 results. No financial figures or decisions are reported yet.
Ecofinity Atomix Board Meeting Date
Ecofinity Atomix Ltd intimated BSE of a Board meeting on 7 November 2026 to consider Q2 and H1 FY27 unaudited results. No financial figures are stated.
Gorani Industries Board Meeting Date
Gorani Industries scheduled its Board meeting for 13 November 2026. It will consider the unaudited results for the September quarter and half-year.
Luxury Time Board Meeting Date
Luxury Time Ltd scheduled its board meeting for 3 Nov 2026 to consider H1 results, CFO replacement, and director remuneration. The filing is a prior intimation; no decisions have been made yet.
India Cements Capital Board Meeting Date
India Cements Capital Ltd scheduled its Audit Committee and Board meeting for 5 Nov 2026 to approve unaudited Q1/H1 FY27 results. Trading window remains closed until results publication on 7 Nov 2026.